Zacks Investment Research lowered shares of Hanger (OTCMKTS:HNGR) from a buy rating to a hold rating in a report released on Wednesday morning.
According to Zacks, “Hanger, Inc. delivers orthotic and prosthetic patient care, and distributes O&P products and rehabilitative solutions. The company’s products & services segment provides Hanger distributes branded and private label O&P devices, products and components and provides rehabilitative solutions. Hanger Inc., formerly known as Hanger Orthoped, is based in AUSTIN, Texas. “
Separately, ValuEngine raised Hanger from a hold rating to a buy rating in a report on Wednesday, May 2nd.
Hanger (OTCMKTS:HNGR) last released its quarterly earnings results on Monday, May 14th. The healthcare company reported $2.32 earnings per share for the quarter. The business had revenue of $285.74 million during the quarter. analysts predict that Hanger will post 0.79 EPS for the current fiscal year.
Hanger, Inc provides orthotic and prosthetic (O&P) patient care services; and distributes O&P devices, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. It operates in two segments, Patient Care and Products & Services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Hanger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanger and related companies with MarketBeat.com's FREE daily email newsletter.